Patient‐reported outcomes in patients with non‐alcoholic fatty liver disease: A narrative review of Chronic Liver Disease Questionnaire‐non‐alcoholic fatty liver disease/non‐alcoholic steatohepatitis
Sakura Yamamura(Kurume University), Takuji Torimura(Omuta hospital), Dan Nakano(Kurume University), Tsubasa Tsutsumi(Kurume University), Yoshio Sumida(Kyoto Prefectural University of Medicine), Lynn H. Gerber(Global Health Council), Hiroshi Isoda(Saga University), Hiroo Matsuse(Kurume University), Yuichiro Eguchi(Saga University), Zobair M. Younossi(Georgetown University), Ryuki Hashida(Kurume University), Hirokazu Takahashi, Atsushi Nakajima(Yokohama City University), Takumi Kawaguchi(Kurume University), Michiaki Okada(Saga University)
Cited by 47
Related Papers
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Hepatology|2023|2.9k
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Journal of Hepatology|2023|2.7k
Sofosbuvir for Previously Untreated Chronic Hepatitis C Infection
|New England Journal of Medicine|2013|1.8k
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
|The Lancet|2019|1.2k
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Annals of Hepatology|2023|789